TQC2938

· Chia Tai Tianqing Pharmaceutical Group; Nanjing Shunxin Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TQC2938, covering 2026-02-10 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease [Phase 2]

See pricing